Expert Opinion and Consultation for Development Issues

• Second opinion on contentious issues and differences of opinion
  • between license partners
  • between multinational parent companies and their Japanese subsidiary

• Expert opinion for mediation, arbitration, and litigation
  • between license partners and collaborators
  • between investors and BioPharma companies